Physician

Neal Shah, M.D.

According to 2025 Medicare claims, Neal Shah, M.D. (NPI: 1851823058) practices hematology/oncology in the Gettysburg, PA market, with the plurality of this provider's patient population coming from Adams, PA. This provider's primary affiliated billing organization is SATISH A SHAH MD PC (NPI: 1982734976; TIN: 23-2586060) and primary practice location at 17325-8598.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 260 traditional Medicare patients, billed 74,331 HCPCS/CPT codes, and received $963,712 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 301 prescription claims across 75 beneficiaries totaling $880,402 in drug costs, led by Imbruvica (Ibrutinib). Open Payments data shows 108 records totaling $2,588. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,067 to $880,402. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$482K$964K2023 Medicare payment: $231,426 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $963,712 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202311611,151$231,426
202426074,331$963,712

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$440K$880K2017 Drug cost: $1,067 (USD; Tot_Drug_Cst)2018 Drug cost: $23,805 (USD; Tot_Drug_Cst)2019 Drug cost: $34,124 (USD; Tot_Drug_Cst)2020 Drug cost: $33,853 (USD; Tot_Drug_Cst)2021 Drug cost: $1,420 (USD; Tot_Drug_Cst)2022 Drug cost: $11,400 (USD; Tot_Drug_Cst)2023 Drug cost: $96,377 (USD; Tot_Drug_Cst)2024 Drug cost: $880,402 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R12$1,067
201856350$23,805
201972427$34,124
202070361$33,853
20211637$1,420
20222895$11,400
20233792$96,377
202475301$880,402

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes4849$136
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more159320$93
96372Injection of drug or substance under skin or into muscle41158$11
36415Insertion of needle into vein for collection of blood sample171428$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count176457$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib12420$209,826
EliquisApixaban592,340$44,219
LetrozoleLetrozole302,520$910
HydroxyureaHydroxyurea12640$298
GabapentinGabapentin17495$45

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.108$2,588AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Neal Shah, M.D.?

Tedicare shows public-source Medicare data for Neal Shah, M.D. (NPI 1851823058), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Neal Shah, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Neal Shah, M.D.?

Neal Shah, M.D. is linked to SATISH A SHAH MD PC (billing NPI 1982734976) in the available physician profile data.

Does Neal Shah, M.D. have Open Payments data?

Neal Shah, M.D. has 108 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.